Admission Date:  [**2116-5-20**]              Discharge Date:   [**2116-5-22**]  Date of Birth:  [**2064-4-29**]             Sex:   F  Service: MEDICINE  Allergies: Sulfa (Sulfonamide Antibiotics)  Attending:[**First Name3 (LF) 1115**] Chief Complaint: altered mental status, fever   Major Surgical or Invasive Procedure: Suprapubic catheter changed on [**5-20**]   History of Present Illness: 52 yo F with PMH of MS, [**Month/Day (4) 37662**] and recurrent UTIs resulting in AMS who was brought in from nursing home for altered mental status and fever of 103F.
Given Vancomycin 1g IV, Cefepime 2g IV and Tylenol.
PERRL Neck: supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Poor inspiratory effort, no wheezes, rales, ronchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly GU: Suprapubic catheter draining bloody, cloudy urine.
Catheter insertion site wihtout erythematous, nontender.
Exam otherwise unchanged since admission  Pertinent Results: ADMISSION LABS: [**2116-5-20**] 10:09AM   GLUCOSE-104* UREA N-8 CREAT-0.7 SODIUM-144 POTASSIUM-3.7 CHLORIDE-112* TOTAL CO2-26 ANION GAP-10 [**2116-5-20**] 10:09AM   CALCIUM-7.8* PHOSPHATE-1.8* MAGNESIUM-1.5* [**2116-5-20**] 10:09AM   WBC-19.2* RBC-3.90* HGB-11.3* HCT-34.6* MCV-89 MCH-29.1 MCHC-32.7 RDW-12.4 [**2116-5-20**] 10:09AM   PLT COUNT-256 [**2116-5-20**] 10:09AM   PT-39.5* PTT-48.4* INR(PT)-3.9* [**2116-5-20**] 03:25AM   LACTATE-2.4* [**2116-5-20**] 01:05AM   LACTATE-2.3* [**2116-5-20**] 01:00AM   WBC-24.9*# RBC-4.44 HGB-12.9 HCT-39.0 MCV-88 MCH-29.0 MCHC-33.0 RDW-12.7 [**2116-5-20**] 01:00AM URINE  BLOOD-LG NITRITE-POS PROTEIN-100 GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-LG [**2116-5-20**] 01:00AM URINE  RBC->182* WBC->182* BACTERIA-MANY YEAST-NONE EPI-0 [**2116-5-20**] 01:00AM URINE  WBCCLUMP-FEW MUCOUS-FEW  DISCHARGE LABS: [**2116-5-22**] 07:27AM BLOOD WBC-8.2 RBC-3.80* Hgb-11.2* Hct-33.7* MCV-89 MCH-29.6 MCHC-33.3 RDW-12.6 Plt Ct-283 [**2116-5-22**] 07:27AM BLOOD PT-21.6* PTT-36.4 INR(PT)-2.1* [**2116-5-22**] 07:27AM BLOOD Glucose-102* UreaN-6 Creat-0.7 Na-144 K-3.8 Cl-108 HCO3-29 AnGap-11 [**2116-5-22**] 07:27AM BLOOD Calcium-8.4 Phos-2.4* Mg-1.9  MICROBIOLOGY: [**2116-5-20**] 1:00 am BLOOD CULTURE                               SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              ESCHERICHIA COLI                              | AMPICILLIN------------   <=2 S AMPICILLIN/SULBACTAM--   <=2 S CEFAZOLIN-------------   <=4 S CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO-----       S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----   <=1 S     Anaerobic Bottle Gram Stain (Final [**2116-5-20**]):       GRAM NEGATIVE ROD(S).
IMPRESSION:  No acute cardiopulmonary process  Brief Hospital Course: 52yo F with PMH MS, MS [**First Name (Titles) **] [**Last Name (Titles) 37662**], neurogenic bladder with suprapubic catheter and recurrent UTIs who presents with UTI and sepsis from pan-sensitive E. coli bacteremia.
# E. coli bacteremia/sepsis:  Patient with longstanding hx of neurogenic bladder, suprapubic catheter and recurrent UTIs presenting with UTI and tachycardia, hypotension, fever.
Hypotension and tachycardia responded to IVF and pt did not require pressors.
She was treated broadly with vancomycin and cefepime and BP stable prior to transfer to floor.
UA suggestive of UTI at rehab day prior to admission, was started on cefpodoxime empirically and received 2 doses however clinically worsensed so broadened to vancomycin and cefepime on admission.
Suprapubic catheter was changed on [**5-20**].
# AMS:  Likely [**12-19**] sepsis, improved back to baseline with treatment as above.
# MS:  Pt followed by neurology for progressive MS.  [**Name13 (STitle) **] baclofen initially held in the setting of hypotension and restarted on tarnsfer to floor.
Please address discontinuing anticoagulation as outpatient.
# Intertrigo: Continued Nystatin topical powder on groin area.
# Communication: Patient & HCP patient's father [**Name (NI) 1193**] ([**Telephone/Fax (1) 85418**] # Code: DNR/DNI during admission # New medication: Ciprofloxacin (stopped cefpodoxime) # Pending studies: blood cultures from [**5-21**] and [**5-22**] no growth at the time of discharge # Follow up: at [**First Name8 (NamePattern2) 3075**] [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **]  Medications on Admission: Preadmission medications listed are correct and complete.
Venlafaxine XR 37.5 mg PO DAILY 2.
Oxybutynin 15 mg PO DAILY 3.
Cefpodoxime Proxetil 100 mg PO Q12H 4.
Acetaminophen 325 mg PO Q8H:PRN pain/fever 5.
Warfarin 4.5 mg PO DAILY16 7.
Docusate Sodium 100 mg PO BID 8.
Senna 1 TAB PO BID 9.
Azo Cranberry *NF* (cranberry ext-C-L. sporogenes) [**Medical Record Number 18595**] mg-mg-million Oral TID supplement 10.
Bisacodyl 10 mg PR DAILY:PRN constipation 11.
Milk of Magnesia 30 mL PO DAILY:PRN constipation 12. alendronate *NF* 70 mg Oral qweekly osteoporosis Drink with a glass of water.
Calcium Carbonate 500 mg PO BID 14.
Baclofen 15 mg PO QID hold for sedation   Discharge Medications: 1.
Acetaminophen 325 mg PO Q8H:PRN pain/fever 2.
Baclofen 15 mg PO QID hold for sedation 3.
Bisacodyl 10 mg PR DAILY:PRN constipation 4.
Calcium Carbonate 500 mg PO BID 5.
Docusate Sodium 100 mg PO BID 6.
Milk of Magnesia 30 mL PO DAILY:PRN constipation 7.
Oxybutynin 15 mg PO DAILY 8.
Senna 1 TAB PO BID 9.
Venlafaxine XR 37.5 mg PO DAILY 10.
Warfarin 4.5 mg PO DAILY16 11.
Ciprofloxacin HCl 500 mg PO Q12H last day [**2116-6-3**] 12. alendronate *NF* 70 mg ORAL QWEEKLY osteoporosis Drink with a glass of water.
Azo Cranberry *NF* (cranberry ext-C-L. sporogenes) [**Medical Record Number 18595**] mg-mg-million Oral TID supplement 14.
We initially treated you with antibiotics through the vein, then changed to oral antibiotics as you improved rapidly.
Medication changes: STARTED ciprofloxacin 500mg [**Hospital1 **] (last day [**2116-6-3**]) STOPPED cefpodoxime  Followup Instructions: You will continue your care at [**First Name8 (NamePattern2) 3075**] [**Last Name (NamePattern1) **] [**Last Name (NamePattern1) **]  Department: SURGICAL SPECIALTIES When: MONDAY [**2116-6-1**] at 1:30 PM With: [**Name6 (MD) 161**] [**Name8 (MD) 6476**], MD [**Telephone/Fax (1) 921**] Building: [**Hospital6 29**] [**Location (un) **] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage    Completed by:[**2116-5-24**
